Selank research guide
Synthetic heptapeptide analogue derived from the tuftsin sequence
A guide to Selank identity and its narrow, geographically concentrated human literature, with explicit limits on generalisation.
AUS Peptide Supply editorial team01 · Identity
What the name identifies
Selank is a synthetic heptapeptide generally described as a tuftsin-derived analogue. Search results often mix animal experiments, gene-expression work and small Russian-language clinical studies. Recording the model and publication type is therefore more informative than summarising them together as one evidence claim.
02 · Evidence position
What the literature can support
Some human comparative research is indexed, but the accessible clinical literature is limited, older and concentrated in a small number of research groups. That is materially different from a replicated, multi-centre approval dossier. Preclinical signalling observations should remain labelled as such.
03 · Study-level map
Evidence and its limits
What direct human comparison is indexed?
A 60-participant Russian-language comparative clinical study evaluated Selank and phenazepam in selected anxiety-related diagnoses.
Limit: The study is small, the accessible record is limited, and one research setting is insufficient for broad conclusions.
Does indexed research equal Australian approval?
Australian supply and advertising status must be checked independently through the ARTG and current TGA rules.
Limit: Publication in another jurisdiction does not establish approval, quality or permitted promotion in Australia.
04 · Analytical context
Questions a batch record should answer
- 01Does intact-mass testing support the declared seven-residue sequence?
- 02Are deletion sequences and closely eluting synthesis by-products visible in the analytical record?
- 03Are purity, content and microbiological quality reported as separate measurements?
05 · Boundary conditions
What this record does not establish
- The human evidence base is not broad or independently replicated enough for confident generalisation.
- Mechanistic or gene-expression studies do not establish a clinical outcome.
- No cognitive, anxiety or administration claim is made by this page.
Sources checked
- 1.Comparison of the effect and tolerability of Selank and phenazepam
PubMed / Zhurnal Nevrologii i Psikhiatrii · 2014 · Primary study
- 2.Understanding your responsibilities when supplying unapproved peptide products
Therapeutic Goods Administration · 2026 · Regulator